Israel
· Delayed Price · Currency is ILS · Price in ILA Matricelf Company Description
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.
The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting.
The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury; and CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications.
The company was incorporated in 2019 and is based in Ness Ziona, Israel.
| Country | Israel |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Gil Hakim |
Contact Details
Address: Golda Meir 3 Ness Ziona, 7651713 Israel | |
| Phone | 972 50 4057353 |
| Website | matricelf.com |
Stock Details
| Ticker Symbol | MTLF |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0011767915 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Alon Sinai | Co-Founder, Deputy Chief Executive Officer, President and Director |
| Gil Hakim | Chief Executive Officer |
| Prof. Tal Dvir Ph.D. | Co-Founder, Chief Scientist and Director |
| Sigal Russo-Gueta | Vice President of Finance and Chief Financial Officer |
| Tamar Harel Adar Ph.D. | Chief Technology Officer |
| Tal Ben Neriah | Vice President of Operations |